Epithalon
Telomerase Activation & Epigenetic Anti-Aging
What is Epithalon?
Epithalon (also spelled epitalon) is a synthetic tetrapeptide with the amino acid sequence Ala-Glu-Asp-Gly. It was developed by the Russian gerontologist Vladimir Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology, and it is a synthetic analog of a shorter peptide fraction, epithalamin, originally isolated from the pineal gland. Within longevity research it is best known for reports that it can activate telomerase — the enzyme (telomerase reverse transcriptase, hTERT) that adds repetitive DNA sequences to the ends of chromosomes — thereby potentially slowing the telomere shortening that accompanies cell division and aging.
The mechanistic story described in the literature involves several proposed effects: induction of telomerase activity and telomere elongation in cultured human cells, modulation of gene expression, and effects on the pineal gland and melatonin rhythms, which connect epithalon to research on circadian regulation and neuroendocrine aging. Some long-running rodent studies from Khavinson's group also reported effects on lifespan and tumor incidence. Because of this body of work, epithalon is often presented as one of the more intriguing longevity peptides in the research literature.
Honesty about the evidence is essential here. Much of the supporting research is decades old, was conducted largely by a single group of investigators, and has not been widely replicated by independent laboratories under modern standards; robust, large, controlled human trials are lacking. Claims that epithalon 'proves' telomere extension or lifespan increase in humans go well beyond what the current published evidence can support, and cell-culture telomerase activation does not straightforwardly translate to whole-organism anti-aging effects. Epithalon is not an approved drug and is not authorized for human use. This information is provided strictly for research and educational purposes only.
Molecular data
Mechanism of action
In preclinical research, Epithalon is associated with the following pathways and targets:
Research highlights
- Activates telomerase reverse transcriptase (hTERT) expression
- Extends telomere length in cell culture and animal studies
- Modulates melatonin production via pineal gland signaling
- 30+ years of research from the St. Petersburg Institute of Bioregulation
Frequently asked questions
What is Epithalon in research?
Epithalon (epitalon) is a synthetic tetrapeptide, Ala-Glu-Asp-Gly, derived from a pineal peptide fraction and developed by Russian gerontology researchers. It is studied in longevity research primarily for its reported ability to activate telomerase and influence telomere length in cell and animal models.
Is epithalon proven to extend telomeres?
No. Some cell-culture and animal studies report telomerase activation and telomere elongation, but this is not the same as proof in humans. The supporting research is limited, largely from a single group, and not widely replicated under modern standards. Cell-culture effects do not reliably translate to whole-organism outcomes, so the claim should be treated as an unverified hypothesis.
How is epithalon thought to work?
Research proposes that epithalon can induce expression of telomerase reverse transcriptase (hTERT), which lengthens telomeres in cultured cells, and that it may modulate gene expression and pineal/melatonin signaling. These are proposed mechanisms drawn largely from preclinical work rather than established human physiology.
What is the difference between epithalon and epithalamin?
Epithalamin is a peptide preparation originally extracted from the pineal gland, while epithalon is the short synthetic tetrapeptide (Ala-Glu-Asp-Gly) designed as a defined analog of that material. Epithalon was created to provide a single, reproducible peptide for study rather than a mixed natural extract.
How strong is the human evidence for epithalon?
It is weak by modern standards. Most data are preclinical or come from older studies by a limited set of investigators, with few independent, large, controlled human trials. Reported longevity or telomere benefits in humans remain unproven. Epithalon is not approved for human use and is offered strictly as a research material.
Source Epithalon at Purgo Labs
≥99% purity, third-party COA verification, and same-day fulfillment.
Shop Epithalon at Purgo Labs ↗Related compounds
For research and educational purposes only. Epithalon is not approved for human use by any regulatory authority, and nothing on this page constitutes medical advice, diagnosis, or treatment. Research findings referenced here are predominantly preclinical.